{"id":"W4402103595","doi":"10.1016/j.jaad.2024.07.426","title":"54025 A Maximum-Use Trial of Ruxolitinib Cream in Children ≥2 to <12 Years Old with Atopic Dermatitis (AD): Patient-Reported Outcomes (PROs) at Week 8","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Ruxolitinib; Dermatology; Pediatrics; Internal medicine; Myelofibrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007330326,0.0001297326,0.000452738,0.0001269813,0.00002339279,0.000008455398,0.0003046314,0.00008940315,0.000005998046],"category_scores_gemma":[0.00004714833,0.00008828764,0.0001766613,0.0002012584,0.0002279672,0.00001005425,0.00008243093,0.0002074406,0.000001558295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001788679,"about_ca_system_score_gemma":0.00008836731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004933668,"about_ca_topic_score_gemma":0.00002330816,"domain_scores_codex":[0.9986687,0.00009322038,0.0006941333,0.0001664793,0.0001838665,0.0001935838],"domain_scores_gemma":[0.9990674,0.00005738739,0.000596342,0.0001726476,0.0000274705,0.00007877435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004918701,0.001306156,0.815941,0.0001094624,0.002113628,0.0001072957,0.0008912804,0.0001983702,0.1488233,0.0004419496,0.009498133,0.01565068],"study_design_scores_gemma":[0.005942768,0.0008342988,0.9224883,0.0001114319,0.0001649918,0.003607251,0.00006710227,0.000006549341,0.04536906,0.0001512065,0.02107019,0.0001868134],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952087,0.0002370963,0.00007992756,0.003997482,0.00005417513,0.0003105869,0.00008083445,0.000004252665,0.00002691756],"genre_scores_gemma":[0.9981083,0.0002530645,0.0006649747,0.0008509812,0.00002717775,0.00001272997,0.000006723473,0.00001518498,0.00006083594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1065473,"threshold_uncertainty_score":0.3600265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01078352826150884,"score_gpt":0.2676892817890777,"score_spread":0.2569057535275689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}